Showing results (1821-1830 of 2,046) with videos related to

Sort By:
Pageof 205
Environmental Research|December 22, 2024
Profiles of the maternal occupational exposome during pregnancy and associations with intrauterine growth: Analysis of the French Longitudinal Study of Children - ELFE studyMarie Tartaglia, Nathalie Costet, Sabyne Audignon-Durand, et al.
The Oncologist|June 28, 2017
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 ResultsSibylle Loibl, Nicholas C Turner, Jungsil Ro, et al.
Scientific Reports|June 7, 2016
Lethal exposure: An integrated approach to pathogen transmission via environmental reservoirsWendy C Turner, Kyrre L Kausrud, Wolfgang Beyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)Nicholas C Turner, Melinda L Telli, Hope S Rugo, et al.
Environmental Health Perspectives|September 10, 2016
Comparing the Health Effects of Ambient Particulate Matter Estimated Using Ground-Based versus Remote Sensing Exposure EstimatesMichael Jerrett, Michelle C Turner, Bernardo S Beckerman, et al.
Environment International|January 7, 2022
Mycotoxin exposure biomonitoring in breastfed and non-exclusively breastfed Nigerian childrenChibundu N Ezekiel, Wilfred A Abia, Dominik Braun, et al.
Wellcome Open Research|September 22, 2020
The direct-medical costs associated with interferon-based treatment for Hepatitis C in VietnamHuyen Anh Nguyen, Graham S Cooke, Jeremy N Day, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 25, 2026
Repeated Disuse Atrophy Imprints a Molecular Memory in Skeletal Muscle: Transcriptional Resilience in Young Adults and Susceptibility in Aged MuscleDaniel C Turner, Truls Raastad, Max Ullrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT TrialsNicholas C Turner, Claire Swift, Lucy Kilburn, et al.
Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.
Pageof 205